113 results
Page 2 of 6
6-K
EX-99.1
3qxuz0
31 Mar 23
Current report (foreign)
6:05am
6-K
EX-99.1
r7p 2n789z0
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
6-K
EX-99.1
7k3xsj5ycax
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
fqubf9g1
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
1r2e0x
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
evb kdio5mnm
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
EX-99.2
9k9 kmqull6jsgpz
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
uhh4cu
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
r0no35h xzbg1cwc
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
EX-99.2
keeqm01 ua455d
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
y32h45eth 4p7
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
ofsbsjf
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
k9nzoi y92gui5yolw
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
ik65hlqq 2zi6zkny
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm